Sign In
Free Newsletter
Supreme Court split over Bayer’s fight against Roundup lawsuits
The U.S. Supreme Court appeared divided over Bayer AG's effort to shut down thousands of lawsuits alleging it failed to warn users that the active ingredient in its Roundup weedkiller causes cancer.
Bayer proposes $7.25B plan to settle Roundup cancer cases
Bayer said it filed a proposed class settlement totaling as much as $7.25 billion aimed at resolving claims that its Roundup weedkiller caused cancer.
Bayer of a deal: Merck selling its OTC business
Germany's Bayer plans to buy Merck & Co.'s consumer health business, creating a combined medicine cabinet of household names from Bayer's aspirin to Merck's Claritin allergy pills.
Like ‘Kleenex’ to ’tissue’, Apple’s ‘iPad’ is the only tablet people know
NEW YORK — Apple is on the verge of doing what few others have: change the English language. When you have a boo-boo, you reach for a Band-Aid not a […]
Newer birth control drugs coming under FDA scrutiny
WASHINGTON — Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from […]
FDA revisits safety of newer birth control drugs
WASHINGTON — Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from […]
Supreme Court lets Baycoll class action proceed; rules in four other cases
WASHINGTON — The Supreme Court will let two West Virginia residents revive a lawsuit against Bayer AG over its anti-cholesterol drug Baycol, which was withdrawn from the market in 2001 […]
Can a federal court stop state class certification?
BOSTON, MA — During oral arguments in Smith v. Bayer, the justices of the U.S. Supreme Court questioned whether a federal court had the authority to stop a state court […]
